Stoke Therapeutics

STOKNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.884 B

$29.20 +4.10%

Close of 22 Sept 2026

Revenue

$184.4M

#2313 by revenue

Earnings

-$6.88M

Loss-making

Shares outstanding

64,526,242

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#116GH ResearchGHRS$1.91B
#117SepternaSEPN$1.88B
#118Stoke TherapeuticsSTOK$1.88B
#119XencorXNCR$1.87B
#120Ani PharmaceuticalsANIP$1.79B

What if Stoke Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$468,553.08

Per share 16,046× higher

Bitcoin $1.74T

$26,991.42

Per share 924× higher

Nvidia $5.52T

$85,480.99

Per share 2,927× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Stoke Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.